Genmab — April 2024

[GeorgeBest]

Thanks E L 09:48. Can you also see what’s the forecast for epcoritamab is by 2030?

[E_L]

'GlobalData’s consensus forecast forecasts that Epkinly will achieve blockbuster status by 2027, with global sales expected to exceed $1.9bn by 2029.' from may last year https://www.clinicaltrialsarena.com/analyst-comment/abbvie-genmab-epkinly-dlbcl/?cf-view

[E_L]

Due to Epkinly's tremendous efficacy, analysts at SVB Securities think that the drug could reach peak annual sales of $3 billion in the U.S. https://www.nasdaq.com/articles/could-this-new-drug-be-a-blockbuster-for-these-2-pharma-collaborators

[E_L]

Sydbank epcoritamab
He estimates the new drug’s annual peak sales potential at USD 3.5bn.https://medwatch.com/News/Pharma___Biotech/article15855008.ece

[E_L]

Drug: Epcoritamab
Companies: AbbVie and Genmab
Used for: Lymphoma
Est. 2028 sales: $1.7 billion https://www.fiercepharma.com/marketing/top-10-most-anticipated-drug-launches-2023

[E_L]

Jefferies analysts previously predicted Epkinly could reach about $2.75 billion in peak sales.

[E_L]

Take your pick

[E_L]

the strength of the competition will greatly affect epco sales, it will be a battle

[lahn1]

wise guy

[E_L]

jyskebank monthly
https://www.jyskebank.dk/wps/wcm/connect/jfo/eb0962c6-b617-408e-8245-d9efbb1679e3/Danske+Aktier+-+April+2024.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE.Z18_P20418S0N05640Q0MBPDFT1PE7-eb0962c6-b617-408e-8245-d9efbb1679e3-oYK6XHG

[royal]

"Vi anbefaler, at investorerne stille og
roligt begynder at stige ombord på toget, inden det kører." Zzzzzzzzzzzzzzzzzzz

[royal]

KYSO. att.: Helge: "Den tålmodige investor II" bør handle om Genmab investorere.

[w]

jyske undrer sig også over fald ovenpå positive nyheder

[lahn1]

Det skrev Jyske også for 3 mdr siden

[Raun]

Hvor er det da ved at være pinligt for Jyske Bank.... - Hold nu op, hvor har de gentaget sig selv mange gange igennem de seneste måneder.... - De må have et ordentlig læs aktier de meget gerne vil af med

[GeorgeBest]

Thanks E L. Do you know how the forecasters see the market share split between epco versus glofi/monesu? 50/50?

[E_L]

no, i don't. would be fun indeed to look at these same analysts forecasts for that

[E_L]

Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors https://investors.bio-techne.com/press-releases/detail/418/bio-techne-appoints-dr-judith-klimovsky-to-board-of -Bio-Techne is a leading supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.

[E_L]

the new Endometrial Cancer trial with GEN1046 will not continue; due to [Enrollment challenged by availability of other treatment options] https://classic.clinicaltrials.gov/ct2/history/NCT06046274?A=10&B=11&C=merged#StudyPageTop

[E_L]

it seems no patients were recruited yet, so the costs should be limited